Treatment Disparities in Parkinson's Disease

被引：63

作者：

Dahodwala, Nabila ^{[1
,2
]}

Xie, Ming ^{[3
]}

Noll, Elizabeth ^{[3
]}

Siderowf, Andrew ^{[1
,2
]}

Mandell, David S. ^{[2
,3
]}

机构：

[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA

[2] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA

[3] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA

来源：

ANNALS OF NEUROLOGY | 2009年 / 66卷 / 02期

关键词：

QUALITY STANDARDS SUBCOMMITTEE; PRIMARY-CARE PATIENTS; AMERICAN ACADEMY; OF-LIFE; DEPRESSION; DIAGNOSIS; AFRICAN; NEUROLOGY; THERAPY; PEOPLE;

D O I：

10.1002/ana.21774

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We sought to identify racial disparities in the treatment of Parkinson's disease (PD). We identified 307 incident PD cases using Pennsylvania State Medicaid claims, and extracted claims for medications, physical therapy, and healthcare visits for the 6 months after diagnosis. After controlling for age, sex, and geography, African-Americans were four times less likely than whites to receive any PD treatment (odds ratio, 0.24; 95% confidence interval, 0.09-0.64), especially indicated medications. In a group with the same healthcare insurance, disparities in PD treatment exist. Physician and community awareness of these racial differences in PD treatment is the first step in addressing healthcare disparities.

引用

页码：142 / 145

页数：4